Home › Research › Topics › trimethylamine-n-oxide
trimethylamine-n-oxide
3 studies tagged trimethylamine-n-oxide, dated 2019-10-14 to 2023-02-02. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases 2023-02-02
- Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far? 2021-02-03
- Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer's disease 2019-10-14
Studies
3 studies carry this tag.
Date range
2019 to 2023
Top journals
- Aging 1
- Biomedicines 1
- European journal of nutrition 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
43/100
Trimethylamine N-oxide (TMAO) is a metabolite produced by the gut microbiota and has been mainly associated with an increased incidence of cardiovascular diseases (CVDs) in humans.
-
The evidence presented in this review shows that TMAO levels can be reduced by some bioactive compounds.
-
Trimethylamine-N-oxide (TMAO), a metabolite of gut microbiota, has been implicated in the pathogenesis of Alzheimer's disease (AD).